Literature DB >> 24825297

Laparoscopic Nissen fundoplication is more effective intreating patients with GERD-related chronic cough than Stretta radiofrequency.

W Liang1, J Wu, Z Hu, Z Wang, G Zhu, C Zhang.   

Abstract

AIM: Chronic cough is the most common extra-esophageal manifestation of gastroesophageal reflux disease (GERD). This study aimed to retrospectively analyze outcomes in patients with GERD-related cough following laparoscopic Nissen fundoplication (LNF) and Stretta radiofrequency (RF) respectively.
METHODS: Medical charts of 83 patients with GERD-related cough that underwent LNF or Stretta RF between 2007 and 2012 were retrieved. Symptom scores (heartburn, regurgitation and cough) and proton pump inhibitors (PPIs) usages were evaluated.
RESULTS: A total of 83 patients with GERD-related cough underwent LNF (n = 35) and Stretta RF (n = 48), and were followed up 36.78±16.12 months (range 1355 months). During the followup, the post-treatment scores were statistically lower as compared with the pre-treatment scores in both groups, while the cough improvement after Stretta was significantly lower than that after LNF (p < 0.001). Besides, 27 (77.1%) patients achieved complete PPI therapy independence after LNF, comparing with 27 (65.1%) after Stretta (p < 0.05). No significant differences in post-treatment complications were observed except for the abdominal distention.
CONCLUSIONS: Even though laparoscopic Nissen fundoplication and Stretta are capable of controlling GERD-related cough effectively and safely in selected patients, laparoscopic Nissen fundoplication could improve more in symptoms and PPI elimination.

Entities:  

Year:  2014        PMID: 24825297

Source DB:  PubMed          Journal:  Minerva Chir        ISSN: 0026-4733            Impact factor:   1.000


  1 in total

1.  Insult of gastroesophageal reflux on airway: clinical significance of pharyngeal nozzle.

Authors:  Zhonggao Wang; Zhiwei Hu; Jimin Wu; Feng Ji; Hongtao Wang; Yungang Lai; Xiang Gao; Yachan Ning; Chengchao Zhang; Zhitong Li; Weitao Liang; Jianjun Liu
Journal:  Front Med       Date:  2014-07-17       Impact factor: 4.592

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.